Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03904251
Title CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Jonsson Comprehensive Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCLA / Jonsson Comprehensive Cancer Center Los Angeles California 90095 United States Details
UC Irvine Health/Chao Family Comprehensive Cancer Center Orange California 92868 United States Details
University of California Davis Comprehensive Cancer Center Sacramento California 95817 United States Details
University of California San Diego San Diego California 92103 United States Details
UCSF Medical Center-Mount Zion San Francisco California 94115 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field